三諾生物(300298.SZ)收到一項醫療器械註冊證和十二項醫療器械註冊變更文件
格隆匯11月21日丨三諾生物(300298.SZ)公佈,公司於近日收到湖南省藥品監督管理局頒發的一項《醫療器械註冊證》和十二項《醫療器械註冊變更文件》。
上述血糖測試系統《醫療器械註冊證》為延續註冊,其餘十二項均為醫療器械註冊證變更。此次醫療器械註冊證的變更,主要是增加了公司便攜式全自動多功能檢測儀配套試劑盒的產品規格,有助於滿足市場多樣化的檢測需求。上述醫療器械註冊證涉及的相關產品實際銷售情況取決於未來市場的推廣效果,對上市公司未來經營業績的影響存在不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.